A detailed history of Vaughan David Investments LLC transactions in Pfizer Inc stock. As of the latest transaction made, Vaughan David Investments LLC holds 12,493 shares of PFE stock, worth $326,941. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,493
Previous 13,381 6.64%
Holding current value
$326,941
Previous $374,000 3.21%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $24,597 - $27,874
-888 Reduced 6.64%
12,493 $362,000
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $17,656 - $20,690
-699 Reduced 4.96%
13,381 $374,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $12,297 - $14,121
-475 Reduced 3.26%
14,080 $391,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $186,228 - $241,890
-7,127 Reduced 32.87%
14,555 $419,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $35,010 - $40,923
-1,091 Reduced 4.79%
21,682 $719,000
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $29,437 - $34,058
-815 Reduced 3.46%
22,773 $835,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $69,287 - $90,201
-1,759 Reduced 6.94%
23,588 $962,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $12,483 - $16,295
299 Added 1.19%
25,347 $1.3 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $9,320 - $11,378
-213 Reduced 0.84%
25,048 $1.1 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $14,005 - $16,606
-301 Reduced 1.18%
25,261 $1.32 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $231,815 - $287,248
-5,067 Reduced 16.54%
25,562 $1.32 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $189,906 - $281,505
4,596 Added 17.65%
30,629 $1.81 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $129,328 - $166,133
-3,295 Reduced 11.23%
26,033 $1.12 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $257,043 - $291,187
-7,158 Reduced 19.62%
29,328 $1.15 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $1.07 Million - $1.21 Million
-32,030 Reduced 46.75%
36,486 $1.32 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $396,853 - $504,633
-11,857 Reduced 14.75%
68,516 $2.52 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $285,464 - $334,914
-8,991 Reduced 10.06%
80,373 $2.95 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $462,251 - $560,779
-15,347 Reduced 14.66%
89,364 $2.92 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $16.5 Million - $23.6 Million
-611,844 Reduced 85.39%
104,711 $3.42 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $260,989 - $296,190
-7,928 Reduced 1.09%
716,555 $28.1 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $58,546 - $75,918
1,802 Added 0.25%
724,483 $26 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $124,215 - $139,465
-3,359 Reduced 0.46%
722,681 $31.3 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $30,225 - $33,207
806 Added 0.11%
726,040 $30.8 Million
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $1.82 Million - $2.08 Million
-47,409 Reduced 6.14%
725,234 $31.7 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $630,042 - $764,203
-18,278 Reduced 2.31%
772,643 $34.1 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $216,513 - $230,825
6,565 Added 0.84%
790,921 $28.7 Million
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $307,357 - $356,576
9,632 Added 1.24%
784,356 $27.8 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $626,917 - $665,181
18,849 Added 2.49%
774,724 $28.1 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $23.2 Million - $25.6 Million
748,303 Added 9882.5%
755,875 $27 Million
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $23.4 Million - $25.7 Million
-753,348 Reduced 99.0%
7,572 $694,000
Q2 2017

Aug 14, 2017

BUY
N/A
760,920
760,920 $25.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vaughan David Investments LLC Portfolio

Follow Vaughan David Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.